(Q34874363)

5 August 2017

1 reference

title

Eplerenone--a novel selective aldosterone blocker (English)

1 reference

5 August 2017

Alan J Zillich

1

1 reference

5 August 2017

Barry L Carter

series ordinal

2

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

Annals of Pharmacotherapy

5 August 2017

published in

1 reference

5 August 2017

volume

36

1 reference

5 August 2017

issue

10

1 reference

5 August 2017

page(s)

1567-1576

1 reference

Mechanism of the antimineralocorticoid effects of spirolactones

5 August 2017

cites work

1 reference

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

Aldosterone in congestive heart failure

21 January 2018

1 reference

Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure

21 January 2018

1 reference

The promise of selective aldosterone receptor antagonists for the treatment of hypertension and congestive heart failure

21 January 2018

1 reference

Aldosterone as a mediator of progressive renal disease: pathogenetic and clinical implications

21 January 2018

1 reference

Aldosterone antagonists in the treatment of hypertension and target organ damage

21 January 2018

1 reference

Aldosterone receptor antagonism normalizes vascular function in liquorice-induced hypertension

21 January 2018

1 reference

Antiandrogenic Effect of Spirolactones: Mechanism of Action

21 January 2018

1 reference

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

21 January 2018

1 reference

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

21 January 2018

1 reference

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

Captopril in heart failure. A double blind controlled trial

21 January 2018

1 reference

Pathophysiology of aldosterone and its antagonists

21 January 2018

1 reference

Role of aldosterone in the remnant kidney model in the rat.

21 January 2018

1 reference

Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients

21 January 2018

1 reference

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

21 January 2018

1 reference

Aldosterone (ALDO) increases transmembrane influx of Na+ in vascular smooth muscle (VSM) cells through increased synthesis of Na+ channels

21 January 2018

1 reference

Prognostic importance of the serum magnesium concentration in patients with congestive heart failure

21 January 2018

1 reference

Mineralocorticoid receptor antagonists: The evolution of utility and pharmacology

21 January 2018

1 reference

Eplerenone suppresses constrictive remodeling and collagen accumulation after angioplasty in porcine coronary arteries

21 January 2018

1 reference

Effect of a selective aldosterone receptor antagonist in myocardial infarction

21 January 2018

1 reference

Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension

21 January 2018

1 reference

Efficacy of eplerenone added to renin-angiotensin blockade in hypertensive patients

21 January 2018

1 reference

Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction

21 January 2018

1 reference

The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study

21 January 2018

1 reference

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

21 January 2018

1 reference

Eplerenone: A Selective Aldosterone Receptor Antagonist (SARA)

21 January 2018

1 reference

Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1C027

1 reference

5 August 2017

1 reference